Studies on competition and antitrust issues in the pharmaceutical industry

"This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay...

Full description

Saved in:
Bibliographic Details
Main Author: Lehnhausen, Ann-Kathrin, (Author)
Format: eBook
Language: English
Published: Wiesbaden, Germany : Springer Gabler/Springer Nature, [2017]
Series: BestMasters.
Subjects:
Pharmaceutical industry.
elektronické knihy
electronic books
ISBN: 9783658165512
9783658165505
Physical Description: 1 online resource (viii, 85 pages) : illustrations

Cover

Table of contents

LEADER 03104cam a2200421Ii 4500
001 97900
003 CZ-ZlUTB
005 20201109180452.0
006 m o d
007 cr bnu---unuuu
008 161119s2017 gw a ob 000 0 eng d
040 |a EBLCP  |b eng  |e rda  |e pn  |c EBLCP  |d OCLCO  |d N$T  |d OCLCQ  |d N$T  |d IDEBK  |d YDX  |d OCLCF  |d IDB  |d AZU  |d UPM  |d Z5A  |d NHM  |d JBG  |d IAD  |d ICW  |d ICN  |d ILO  |d OCLCQ  |d COO  |d OCLCQ  |d IAS  |d OCLCQ  |d MERUC  |d U3W  |d CAUOI  |d IOG  |d KSU  |d OCLCA  |d ESU  |d OCLCQ  |d LVT  |d BRX  |d OCLCQ  |d ERF  |d OCLCQ  |d U@J  |d OCLCQ  |d SFB  |d SRU 
020 |a 9783658165512  |q (electronic bk.) 
020 |z 9783658165505  |q (print) 
024 7 |a 10.1007/978-3-658-16551-2  |2 doi 
035 |a (OCoLC)963696105  |z (OCoLC)963351279  |z (OCoLC)966391903  |z (OCoLC)974650107 
100 1 |a Lehnhausen, Ann-Kathrin,  |e author. 
245 1 0 |a Studies on competition and antitrust issues in the pharmaceutical industry /  |c Ann-Kathrin Lehnhausen ; with a preface by Dr. Johannes Paha. 
264 1 |a Wiesbaden, Germany :  |b Springer Gabler/Springer Nature,  |c [2017] 
300 |a 1 online resource (viii, 85 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
490 1 |a BestMasters 
504 |a Includes bibliographical references (pages 71-85). 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a "This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug's patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies."--Provided by publisher. 
505 0 |a The Pharmaceutical Industry -- Anticompetitive actions taken by one firm only -- Interactions Between Two or More Firms. 
590 |a SpringerLink  |b Springer Complete eBooks 
650 0 |a Pharmaceutical industry. 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
700 1 |a Paha, Johannes,  |e writer of preface. 
776 0 8 |i Print version:  |a LEHNHAUSEN, ANN-KATHRIN.  |t Studies on competition and antitrust issues in the pharmaceutical industry.  |b 1ST ed. 2017.  |d [Place of publication not identified] : SPRINGER GABLER, 2017  |z 9783658165505  |z 3658165502  |w (DLC) 2016959244  |w (OCoLC)962354692 
830 0 |a BestMasters. 
856 4 0 |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-3-658-16551-2  |y Plný text 
992 |c NTK-SpringerBM 
999 |c 97900  |d 97900 

Similar Items